Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
The price of Terns Pharmaceuticals Inc (NASDAQ: TERN) closed at $4.37 in the last session, down -2.02% from day before closing price of $4.46. In other words, the price has decreased by -$2.02 from its previous closing price. On the day, 0.98 million shares were traded. TERN stock price reached its highest trading level at $4.47 during the session, while it also had its lowest trading level at $4.225.
Ratios:
We take a closer look at TERN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 32.99 and its Current Ratio is at 32.99. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on October 31, 2024, initiated with a Outperform rating and assigned the stock a target price of $82.
On June 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $16.
On June 07, 2023, Jefferies started tracking the stock assigning a Buy rating and target price of $18.Jefferies initiated its Buy rating on June 07, 2023, with a $18 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 30 ’24 when Jung Melita Sun bought 2,250 shares for $5.11 per share. The transaction valued at 11,498 led to the insider holds 2,250 shares of the business.
Burroughs Amy L. bought 510 shares of TERN for $2,606 on Nov 30 ’24. The Chief Executive Officer now owns 19,609 shares after completing the transaction at $5.11 per share. On Jan 02 ’25, another insider, Kuriakose Emil, who serves as the Chief Medical Officer of the company, sold 4,481 shares for $5.71 each. As a result, the insider received 25,607 and left with 54,269 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TERN now has a Market Capitalization of 371182976 and an Enterprise Value of -384819.
Stock Price History:
The Beta on a monthly basis for TERN is -0.36, which has changed by -0.1710037 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, TERN has reached a high of $11.40, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is -21.99%, while the 200-Day Moving Average is calculated to be -36.45%.
Shares Statistics:
According to the various share statistics, TERN traded on average about 1.78M shares per day over the past 3-months and 2172250 shares per day over the past 10 days. A total of 84.92M shares are outstanding, with a floating share count of 62.32M. Insiders hold about 26.63% of the company’s shares, while institutions hold 71.68% stake in the company. Shares short for TERN as of 1736899200 were 7638295 with a Short Ratio of 4.29, compared to 1734048000 on 6204533. Therefore, it implies a Short% of Shares Outstanding of 7638295 and a Short% of Float of 9.879999999999999.
